Results 171 to 180 of about 57,702 (266)

Techniques for subretinal injections in animals

open access: yesVeterinary Ophthalmology, Volume 28, Issue 2, Page 506-518, March 2025.
Abstract Subretinal injections are not commonly performed during clinical treatment of animals but are frequently used in laboratory animal models to assess therapeutic efficacy and safety of gene and cell therapy products. Veterinary ophthalmologists are often employed to perform the injections in the laboratory animal setting, due to knowledge of ...
Ryan F. Boyd, Simon M. Petersen‐Jones
wiley   +1 more source

Low‐Cost and Detunable Wireless Resonator Glasses for Enhanced Eye MRI With Concurrent High‐Quality Whole‐Brain MRI

open access: yesMagnetic Resonance in Medicine, Volume 96, Issue 1, Page 499-507, July 2026.
ABSTRACT Purpose To develop a wearable wireless resonator glasses design that enhances eye MRI signal‐to‐noise ratio (SNR) without compromising whole‐brain image quality at 7 T. Methods The device integrates two detunable LC loop resonators into a lightweight, 3D‐printed frame positioned near the eyes.
Ming Lu   +7 more
wiley   +1 more source

Use of antivascular endothelial growth factor for diabetic macular edema

open access: yesClinical Ophthalmology, 2010
Rushmia Karim, Benjamin TangUniversity of Sydney School of Public Health, Concord Repatriation General Hospital, Concord, NSW, AustraliaBackground: Diabetic macular edema (DME) is one of the manifestations of diabetic retinopathy leading to loss of ...
Rushmia Karim, Benjamin Tang
doaj  

Innovative Drug Delivery Systems for the Treatment of Glaucoma

open access: yesMedComm – Biomaterials and Applications, Volume 5, Issue 2, June 2026.
This review aims to provide a comprehensive overview of current topical drug delivery strategies for ocular hypotensive agents in glaucoma therapy. Additionally, it discusses the potential impact of emerging nanotechnological and biomaterial‐based systems in shaping the future of ophthalmic drug delivery, with an emphasis on enhancing efficacy, safety,
Jing Chu   +9 more
wiley   +1 more source

The prechoroidal cleft in neovascular age‐related macular degeneration

open access: yesActa Ophthalmologica, Volume 104, Issue 4, Page 364-375, June 2026.
Abstract The prechoroidal cleft is a lenticular, hypo‐reflective space on optical coherence tomography imaging, located between a band of fibrovascular material underneath the retinal pigment epithelium (RPE) and Bruch's membrane. It occurs in 8%–22% of neovascular age‐related macular degeneration (nAMD) eyes, most often with macular neovascularization
Niels J. Brouwer   +3 more
wiley   +1 more source

Vitreoretinal complications and surgical outcomes in patients with X‐linked retinoschisis

open access: yesActa Ophthalmologica, Volume 104, Issue 4, Page 410-422, June 2026.
Abstract Purpose X‐linked retinoschisis (XLRS) is an inherited vitreoretinal disorder characterized by macular retinoschisis. In a subgroup of patients, peripheral retinoschisis can occur, potentially leading to complications such as vitreous haemorrhage (VH) and retinal detachment (RD).
Jonathan Hensman   +11 more
wiley   +1 more source

Retinal Assessment and the Retina–Choroid Link in Precapillary Pulmonary Hypertension: A Single-Center Cross-Sectional Study

open access: yesClinical Ophthalmology
Aleksandra Leoniuk,1 Katarzyna Ptaszynska,2 Anna Szwedowicz,1 Emilia Sawicka-Smiarowska,2 Remigiusz Kazimierczyk,2 Agnieszka Zonenberg,1 Barbara Pieklarz,1 Daniel Baldyga,1 Iwona Obuchowska,1 Joanna Konopinska,1 Karol A Kaminski,2 Diana A Dmuchowska1 ...
Leoniuk A   +11 more
doaj  

Central Macular Thickness in Diabetic Retinopathy- A Comparative Study

open access: yesAnnals of International medical and Dental Research, 2017
Farhat Abrar   +2 more
openaire   +1 more source

Long‐term outcomes of nationwide coordinated neovascular AMD treatment: A study based on Polish national registry

open access: yesActa Ophthalmologica, Volume 104, Issue 4, Page e382-e396, June 2026.
Abstract Purpose To evaluate long‐term outcomes of anti‐VEGF therapy for nAMD using the Polish Retinal Therapeutic Program Monitoring Registry. Methods The cohort consisted of 63 840 eyes with nAMD qualified for treatment from 2016 to 2022, with follow‐up through 31 October 2023. Long‐term follow‐up (>5 years) was conducted for 7631 eyes.
Sławomir Teper   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy